Xtx Topco LTD Emergent Bio Solutions Inc. Transaction History

Xtx Topco LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.86 - $6.98 $80,032 - $300,335	43,028 Added 218.02%	62,764 $428,000
Q1 2024 May 13, 2024	BUY	$1.5 - $3.41 $29,604 - $67,299	19,736 New	19,736 $49,000
Q3 2023 Nov 13, 2023	BUY	$3.17 - $7.91 $55,906 - $139,500	17,636 Added 127.56%	31,462 $106,000
Q2 2023 Aug 14, 2023	BUY	$7.35 - $13.21 $101,621 - $182,641	13,826 New	13,826 $101,000
Q4 2022 Feb 14, 2023	BUY	$11.0 - $21.45 $168,377 - $328,335	15,307 New	15,307 $180,000
Q2 2021 Aug 12, 2021	SELL	$56.61 - $80.46 $273,992 - $389,426	-4,840 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$86.23 - $125.19 $417,353 - $605,919	4,840 New	4,840 $450,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.